GlassScriptPhysician profile
Genia Bekker
NPI 1679540926
$2,952.78
in general payments reported to CMS, 2019-2025
23 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $295 · 2021: $357 · 2022: $512 · 2023: $570 · 2024: $597 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $552.67 | 2023-2025 | Gemtesa, Myfembree |
| Abbvie INC. | $392.69 | 2019-2022 | |
| Pfizer INC. | $388.53 | 2019-2024 | |
| Astellas Pharma US INC | $362.46 | 2019-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $198.18 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Urovant Sciences INC | $166.64 | 2022 | |
| Exeltis, USA INC. | $134.65 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $111.16 | 2019-2022 | |
| Evofem Biosciences, INC. | $110.22 | 2021-2024 | Phexxi |
| Mayne Pharma Commercial LLC | $80.01 | 2023-2025 | |
| Novo Nordisk INC | $76.75 | 2020-2022 | |
| Myovant Sciences INC. | $62.41 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $61.87 | 2019-2021 | |
| Hologic Sales and Service, LLC | $51.27 | 2021-2022 | |
| Organon LLC | $40.93 | 2022-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $25.00 | 2022 | |
| Mylan Pharmaceuticals INC. | $24.92 | 2020 | |
| Biogen, INC. | $22.73 | 2025 | Zurzuvae |
| Duchesnay USA Incorporated | $22.08 | 2019 | |
| Amag Pharmaceuticals, INC. | $22.00 | 2019 | |
| Avion Pharmaceuticals | $15.71 | 2020 | |
| Agile Therapeutics, INC. | $15.35 | 2021 | |
| Millicent US INC | $14.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Genia Bekker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.